By Ransdell Pierson (Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, bolstering J&J's role in the field after it acquired another experimental prostate-... More »
By Genevra Pittman NEW YORK (Reuters Health) - Watching and routinely examining men with early, slow-growing prostate cancer is more effective and cheaper than sending them to surgery or radiation right away, according to a new study. The findings... More »
By Genevra Pittman NEW YORK (Reuters Health) - After being diagnosed with prostate cancer, men who eat a diet high in vegetable fats, such as those in nuts and olive oil, may be less likely to have their disease spread, a new study suggests. Resea... More »
By Andrew M. Seaman NEW YORK (Reuters Health) - Despite dietary supplements being popular among prostate cancer patients, a new review of past research says they are not effective treatments for the disease. Pulling together data from eight random... More »